dopetalk does not endorse any advertised product nor does it accept any liability for it's use or misuse

This website has run out of funding so feel free to contribute if you can afford it (see footer)

Author Topic: How the U.S. Pays 3 Times More for Drugs  (Read 5802 times)

Offline Chip (OP)

  • Server Admin
  • Hero Member
  • *****
  • Administrator
  • *****
  • Join Date: Dec 2014
  • Location: Australia
  • Posts: 6648
  • Reputation Power: 0
  • Chip has hidden their reputation power
  • Gender: Male
  • Last Login:Today at 05:53:23 PM
  • Deeply Confused Learner
  • Profession: IT Engineer
How the U.S. Pays 3 Times More for Drugs
« on: October 14, 2015, 12:51:17 PM »
source: wWw.scientificamerican.com/article/how-the-u-s-pays-3-times-more-for-drugs/

How the U.S. Pays 3 Times More for Drugs



In Britain the world's 20 top-selling medicines are three times cheaper than in the U.S.

(October 13, 2015, by Ben Hirschler)

LONDON (Reuters) - U.S. prices for the world's 20 top-selling medicines are, on average, three times higher than in Britain, according to an analysis carried out for Reuters.

The finding underscores a transatlantic gulf between the price of treatments for a range of diseases and follows demands for lower drug costs in America from industry critics such as Democratic presidential candidate Hillary Clinton.

The 20 medicines, which together accounted for 15% of global pharmaceuticals spending in 2014, are a major source of profits for companies including AbbVie, AstraZeneca , Merck, Pfizer and Roche.

Researchers from Britain's University of Liverpool also found U.S. prices were consistently higher than in other European markets. Elsewhere, U.S. prices were six times higher than in Brazil and 16 times higher than the average in the lowest-price country, which was usually India.

The United States, which leaves pricing to market competition, has higher drug prices than other countries where governments directly or indirectly control medicine costs.

That makes it by far the most profitable market for pharmaceutical companies, leading to complaints that Americans are effectively subsidizing health systems elsewhere.

Manufacturers say decent returns are needed to reward high-risk research and prices reflect the economic value provided by medicines. They also point to higher U.S. survival rates for diseases such as cancer and the availability of industry-backed access schemes for poorer citizens.

In recent years, the price differential has been exacerbated by above-inflation annual increases in U.S. drug prices at a time when governments in Europe have capped costs or even pushed prices down.

In fact, U.S. prices for top brand-name drugs jumped 127% between 2008 and 2014, compared with an 11% rise in a basket of common household goods, according to Express Scripts, the largest U.S. manager of drug plans.

In Europe, meanwhile, the impact of austerity on health budgets since the financial crisis has led industry executives to complain of single-digit percentage annual price declines.

The U.S. Pharmaceutical Research and Manufacturers of America (PhRMA) says international comparisons are misleading because list prices do not take into account discounts available as a result of "aggressive negotiation" by U.S. insurers.

These discounts can drive down the actual price paid by U.S. insurance companies substantially. However, similar confidential discounts are also offered to big European buyers such as Britain's National Health Service.

"The U.S. has a competitive marketplace that works to control costs while encouraging the development of new treatments and cures," Holly Campbell, PhRMA's director of communications, said in a statement.

PhRMA also argues that while Americans may pay more for drugs when they first come out, they pay less as drugs get older, since nearly 90% of all medicines prescribed to U.S. patients are now cheap generics.

In Britain, generics account for just over three-quarters of prescriptions and that level is lower in other parts of Europe.

Still, the United States is slower to see the arrival of generic competition to some top-selling drugs, which explains some of the differences in pricing for certain medicines on the top-20 list.

Overall, the analysis found that price differentials were slightly smaller for complex antibody-based drugs, which are used to treat conditions like cancer and rheumatoid arthritis.

Many of the biggest differences were evident for older drugs, reflecting the fact that prices are typically hiked each year in the United States, said University of Liverpool drug pricing expert Andrew Hill.

"It shows the U.S. drug pricing situation isn't just a matter of isolated cases like Turing Pharmaceuticals," he said.

The latest furore over U.S. drug costs was prompted by the decision by unlisted Turing to hike the cost of an old drug against a parasitic infection to $750 a pill from $13.50. It has since promised to roll back the increase.

The same medicine is sold in Britain by GlaxoSmithKline for 43 pence (66 cents).

[end]
friendly
0
funny
0
informative
0
agree
0
disagree
0
like
0
dislike
0
No reactions
No reactions
No reactions
No reactions
No reactions
No reactions
No reactions
Our Discord Server invitation link is https://discord.gg/jB2qmRrxyD

Z

  • Guest
Re: How the U.S. Pays 3 Times More for Drugs
« Reply #1 on: October 14, 2015, 06:43:55 PM »
It is a bit of a misnomer that these companies invest so much in research.  A great deal of the basic work is done in universities through public and private grants.  It doesn't justify the price gouging.

Another interesting thing to look in to is how much the us spends per capita on Medicare costs.  It is close to the cost of running the Canadian universal health system which covers the whole population if I remember right.

The main difference is in a single payer (gov) system, the government tends to set the prices they will pay for x level of service.  In the us the hospitals and HMO set rates they charge for x, and the government pays at these higher rates.  Veteran affairs accounts for a great deal as well, but they are usually a single payer system.

Per capita tax spending on government subsidised healthcare is higher in the us if I remember right.  Not caffeinated enough to look at the minute.

Edit: no coffee required it turns out: https://en.m.wikipedia.org/wiki/Comparison_of_the_health_care_systems_in_Canada_and_the_United_States. Excuse the mobile link.
« Last Edit: October 14, 2015, 06:46:33 PM by Z »
friendly
0
funny
0
informative
0
agree
0
disagree
0
like
0
dislike
0
No reactions
No reactions
No reactions
No reactions
No reactions
No reactions
No reactions

Offline LoneRanger7

  • Jr. Member
  • **
  • Join Date: Oct 2015
  • Location: Tampa
  • Posts: 84
  • Reputation Power: 5
  • LoneRanger7 is new on the scene.
  • Last Login:December 04, 2017, 07:24:00 AM
  • Better living through chemistry
Re: How the U.S. Pays 3 Times More for Drugs
« Reply #2 on: October 15, 2015, 09:14:08 AM »
Like the damn hep c drug that shit is $100K here, I know someone whose insurance covered it because they were stage 4 cirrhotic.
friendly
0
funny
0
informative
0
agree
0
disagree
0
like
0
dislike
0
No reactions
No reactions
No reactions
No reactions
No reactions
No reactions
No reactions

Tags:
 

Related Topics

  Subject / Started by Replies Last post
1 Replies
9684 Views
Last post July 30, 2015, 10:13:32 AM
by Roman Totale
9 Replies
9677 Views
Last post October 28, 2015, 03:59:19 PM
by LoneRanger7
11 Replies
11585 Views
Last post December 01, 2018, 12:39:48 AM
by bobbytarantino
4 Replies
7649 Views
Last post February 11, 2016, 06:42:44 AM
by Narkotikon
2 Replies
7189 Views
Last post February 13, 2016, 12:10:15 AM
by Jega
8 Replies
11000 Views
Last post March 09, 2016, 04:30:43 PM
by neighbor
0 Replies
2210 Views
Last post August 25, 2016, 12:12:13 AM
by Chip
5 Replies
9524 Views
Last post February 20, 2017, 06:18:51 AM
by Z
5 Replies
8468 Views
Last post July 13, 2017, 07:27:14 AM
by Mr.pooper
0 Replies
1755 Views
Last post October 04, 2017, 08:12:21 PM
by Chip


dopetalk does not endorse any advertised product nor does it accept any liability for it's use or misuse





TERMS AND CONDITIONS

In no event will d&u or any person involved in creating, producing, or distributing site information be liable for any direct, indirect, incidental, punitive, special or consequential damages arising out of the use of or inability to use d&u. You agree to indemnify and hold harmless d&u, its domain founders, sponsors, maintainers, server administrators, volunteers and contributors from and against all liability, claims, damages, costs and expenses, including legal fees, that arise directly or indirectly from the use of any part of the d&u site.


TO USE THIS WEBSITE YOU MUST AGREE TO THE TERMS AND CONDITIONS ABOVE


Founded December 2014
SimplePortal 2.3.6 © 2008-2014, SimplePortal